Sector News

Bayer to float MaterialScience plastics unit

September 18, 2014
Chemical Value Chain
(MarketWatch) – Bayer AG on Thursday said it plans to float its plastics business, to focus entirely on its life-sciences operations.
 
“In this way Bayer would position itself as a world-leading company in the field of human, animal and plant health,” the German pharmaceutical company said in a statement, confirming an earlier report by The Wall Street Journal.
 
Bayer’s BAYN, +4.89%  plans are subject to approval by the company’s supervisory board, which is due to meet later Thursday.
 
The Journal reported Wednesday that Bayer planned to shed its MaterialScience business but hadn’t decided what form the separation would ultimately take, be it an outright sale, initial public offering or spin off, people familiar with the matter said.
 
By Neetha Mahadevan
 

Related News

July 31, 2021

Maire Tecnimont awarded €430-million contract for Repsol’s Portugal polymers expansion 

Chemical Value Chain

The total contract value is approximately €430 million. The project scope of work entails complete engineering services, equipment and material supply, installation and construction activities and, as an optional part of the scope, commissioning and start up.

July 31, 2021

Lenzing invests €23.3 million in new wastewater-treatment plant in the U.K. 

Chemical Value Chain

Once it has implemented this project, Lenzing will have biological wastewater treatment plants that meet the best available techniques (BAT) quality standard at all its production sites.

July 31, 2021

Is hydrogen just oil and gas greenwashed?

Chemical Value Chain

The debate over the position of hydrogen in the new energy revolution has come to the fore again thanks to Japan’s hosting of the Olympic Games. But rather than showcasing how green this miracle new fuel is, it has highlighted its many problems.

Send this to a friend